Cita APA (7a ed.)

Michels, S. Y. F., Scheel, A. H., Wündisch, T., Heuckmann, J. M., Menon, R., Puesken, M., . . . Wolf, J. (2017). ALK G1269A mutation as a potential mechanism of acquired resistance to crizotinib in an ALK-rearranged inflammatory myofibroblastic tumor. Nature Portfolio.

Cita Chicago Style (17a ed.)

Michels, Sebastian Y. F., et al. ALK G1269A Mutation as a Potential Mechanism of Acquired Resistance to Crizotinib in an ALK-rearranged Inflammatory Myofibroblastic Tumor. Nature Portfolio, 2017.

Cita MLA (8a ed.)

Michels, Sebastian Y. F., et al. ALK G1269A Mutation as a Potential Mechanism of Acquired Resistance to Crizotinib in an ALK-rearranged Inflammatory Myofibroblastic Tumor. Nature Portfolio, 2017.